Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.23.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
ASSETS    
Available-for-sale securities, at fair value (amortized cost $9,278,950 and $8,114,627, respectively; allowance for credit losses $5,360 and $6,958, respectively) $ 8,963,203 $ 7,778,734
Mortgage servicing rights, at fair value 3,273,956 2,984,937
Cash and cash equivalents 699,081 683,479
Restricted cash 322,603 443,026
Accrued interest receivable 39,700 36,018
Due from counterparties 248,607 253,374
Derivative assets, at fair value 16,469 26,438
Reverse repurchase agreements 289,288 1,066,935
Other assets 157,092 193,219
Total Assets 14,009,999 13,466,160
Liabilities    
Repurchase agreements 9,067,824 8,603,011
Revolving credit facilities 1,455,421 1,118,831
Term notes payable 398,653 398,011
Convertible senior notes 267,791 282,496
Derivative liabilities, at fair value 14,976 34,048
Due to counterparties 267,050 541,709
Dividends payable 55,675 64,504
Accrued interest payable 120,504 94,034
Commitments and contingencies (see Note 15) 0 0
Other liabilities 146,096 145,991
Total Liabilities 11,793,990 11,282,635
Stockholders' Equity    
Preferred stock, par value $0.01 per share; 100,000,000 shares authorized and 25,578,232 and 26,092,050 shares issued and outstanding, respectively ($639,456 and $652,301 liquidation preference, respectively) 618,579 630,999
Common stock, par value $0.01 per share; 175,000,000 shares authorized and 96,165,535 and 86,428,845 shares issued and outstanding, respectively 962 864
Additional paid-in capital 5,824,509 5,645,998
Accumulated other comprehensive loss (309,086) (278,711)
Cumulative earnings 1,476,462 1,453,371
Cumulative distributions to stockholders (5,395,417) (5,268,996)
Total Stockholders’ Equity 2,216,009 2,183,525
Total Liabilities and Stockholders’ Equity $ 14,009,999 $ 13,466,160